| A Comparison Of A Single PF-04634817 Tablet Dose Compared With A Solution In Healthy Volunteers (NCT01247883) | Pfizer | 2010-10-01 |
| BIBW 2992 (Afatinib) and Vinorelbine in Japanese Patients With Advanced Solid Tumours (NCT01214616) | Boehringer Ingelheim | 2010-10-01 |
| Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSI (NCT01885702) | Radboud University Medical Center | 2010-10-01 |
| A Drug-Drug Interaction Study to Study the Effect of AZD1981 on Warfarin (NCT01199341) | AstraZeneca | 2010-10-01 |
| Ridaforolimus and Vorinostat in Treating Patients With Advanced Solid Tumors or Lymphoma (NCT01169532) | Fox Chase Cancer Center | 2010-10-01 |
| Cellular and Humoral Immune Response to Primary and Secondary Immunization With Subvirion H5N1 Vaccines (NCT01086566) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-10-01 |
| Study of Hydroxychloroquine Before Surgery in Patients With Primary Renal Cell Carcinoma (NCT01144169) | University of Pittsburgh | 2010-10-01 |
| Physiological Effects of Grape Seed Extract in Diastolic Heart Failure (NCT01185067) | University of Michigan | 2010-10-01 |
| Food-Effect Pharmacokinetic Study of PL2200 (NCT01244100) | PLx Pharma | 2010-10-01 |
| Nutrition, Neuromuscular Electrical Stimulation (NMES) and Secondary Progressive Multiple Sclerosis (SPMS) (NCT01381354) | University of Iowa | 2010-10-01 |
| Effect of Polyphenols on Peripheral Vascular Disease. (NCT01947712) | University of Roma La Sapienza | 2010-10-01 |
| A Study of ND0801 in Attention Deficit/Hyperactivity Disorder (ADHD) (NCT01174355) | NeuroDerm Ltd. | 2010-10-01 |
| AMD 3100 for Treatment of Myelokathexis (NCT01058993) | University of Washington | 2010-10-01 |
| A Pharmacokinetics (PK) and Safety Study of Oral Fampridine-PR 10 mg in Chinese, Japanese, and Caucasian Adult Healthy Volunteers (NCT01215084) | Biogen | 2010-10-01 |
| Study of Pre-surgery Gemcitabine + Hydroxychloroquine (GcHc) in Stage IIb or III Adenocarcinoma of the Pancreas (NCT01128296) | Amer Zureikat | 2010-10-01 |
| Entinostat And Imatinib Mesylate In Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (NCT01383447) | National Cancer Institute (NCI) | 2010-10-01 |
| Adult Stem Cell Therapy for Repairing Articular Cartilage in Gonarthrosis (NCT01227694) | Banc de Sang i Teixits | 2010-10-01 |
| A Study to Evaluate the Effects of Diltiazem, a Moderate CYP3A4/A5 Inhibitor, on the Pharmacokinetics and Pharmacodynamics of E5555 and Its Metabolites in Healthy Subjects (NCT01261156) | Eisai Inc. | 2010-10-01 |
| Drug-Drug Interaction Study of VX-770 and VX-809 in Healthy Subjects (NCT01216046) | Vertex Pharmaceuticals Incorporated | 2010-10-01 |
| Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast Cancer (NCT01238029) | Sponsor GmbH | 2010-10-01 |
| The Pharmacokinetics and Cardiac Properties of Elacytarabine (CP-4055) (NCT01258816) | Clavis Pharma | 2010-10-01 |
| Safety Study of Recombinant Human Alpha-mannosidase for the Treatment of Patients With Alpha-mannosidosis (NCT01268358) | Zymenex A/S | 2010-10-01 |
| Human Menstrual Blood-derived Mesenchymal Stem Cells for Patients With Liver Cirrhosis (NCT01483248) | S-Evans Biosciences Co., Ltd. | 2010-10-01 |
| Panobinostat and Fluorouracil Followed By Leucovorin Calcium in Treating Patients With Stage IV Colorectal Cancer Who Did Not Respond to Previous Fluorouracil-Based Chemotherapy (NCT01238965) | University of Southern California | 2010-10-01 |
| Trial of Carfilzomib Plus Melphalan and Prednisone in Elderly Untreated Patients With Multiple Myeloma (CARMYSAP) (NCT01279694) | Nantes University Hospital | 2010-10-01 |
| Hydroxychloroquine for Discordant CD4 Responders on Highly Active Antiretroviral Therapy (HAART) (NCT01232660) | St Stephens Aids Trust | 2010-10-01 |
| Microbicide Safety and Acceptability in Young Men (NCT01283360) | CONRAD | 2010-10-01 |
| Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA (NCT01269853) | Northwell Health | 2010-10-01 |
| TMC435-TiDP16-C123 - A Study in Healthy Volunteers Investigating the Pharmacokinetic Interaction Between TMC435 and the Antiretroviral Agents Efavirenz and Raltegravir (NCT01241773) | Tibotec Pharmaceuticals, Ireland | 2010-10-01 |
| Dose Escalation Study of ARQ 736 in Adult Subjects With Advanced Solid Tumors Harboring BRAF and/or NRAS Mutations (NCT01225536) | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2010-10-01 |
| Carfilzomib in Patients With Relapsed Acute Myeloid or Acute Lymphoblastic Leukemia (NCT01137747) | Washington University School of Medicine | 2010-10-01 |
| Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fed Condition (NCT01923259) | Dr. Reddy's Laboratories Limited | 2010-10-01 |
| Myocet® in Children With Relapsed or Refractory Non-brainstem Malignant Glioma (NCT02861222) | Central Hospital, Nancy, France | 2010-10-01 |
| Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed Disease (NCT00871702) | Washington University School of Medicine | 2010-10-01 |
| Clinical Evaluation of Bioadhesive Gels for Oral Cancer Chemoprevention (NCT01192204) | Ohio State University | 2010-10-01 |
| A Study Evaluating the Safety, Tolerability and Pharmacokinetics of GDC-0917 Administered to Patients With Refractory Solid Tumors or Lymphoma (NCT01226277) | Genentech, Inc. | 2010-10-01 |
| Accuracy and Safety Study of the Magnetecs CGCI System for Intracardiac Mapping (NCT01222156) | Magnetecs Corporation | 2010-10-01 |
| Caveolin-1 and Vascular Dysfunction (NCT01426529) | Brigham and Women's Hospital | 2010-10-01 |
| Bioequivalence Study of Pediatric Formulations to Treat HIV Infection (NCT01469520) | Elim Pediatric Pharmaceuticals Inc. | 2010-10-01 |
| Safety Study of GRNOPC1 in Spinal Cord Injury (NCT01217008) | Lineage Cell Therapeutics, Inc. | 2010-10-01 |
| A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer (NCT01228760) | Astellas Pharma Inc | 2010-10-01 |
| A Study to Assess AFM13 in Patients With Hodgkin Lymphoma (NCT01221571) | Affimed GmbH | 2010-10-01 |
| Cardiopulmonary Resuscitation (CPR) Dissemination Study Using Nurses and Volunteers (NCT01252316) | University of Pennsylvania | 2010-10-01 |
| Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma (NCT01204476) | National Cancer Institute (NCI) | 2010-10-01 |
| Controlled Clinical Trial of Traditional Chinese Medicine Mouthrinse (NCT01637948) | The University of Hong Kong | 2010-10-01 |
| Effect of Activated Charcoal and Time of Dose on the Pharmacokinetics of LY2624803 in Healthy Subject (NCT01236105) | Eli Lilly and Company | 2010-10-01 |
| An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of Two Controlled Release Pregabalin Tablets As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule (NCT01202422) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2010-10-01 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics After High Single Ascending Oral Doses of AZD1656 in T2DM Patients (NCT01221545) | AstraZeneca | 2010-10-01 |
| Umbilical Cord Mesenchymal Stem Cells Infusion Via Hepatic Artery in Cirrhosis Patients (NCT01224327) | Qingdao University | 2010-10-01 |
| Mechanical Bone Stimulation and Adenosine 5'-Triphosphate (ATP) Release in Humans (NCT01130428) | Maastricht University Medical Center | 2010-10-01 |
| Chemoembolization Using Irinotecan in Treating Patients With Liver Metastases From Metastatic Colon or Rectal Cancer (NCT01285102) | Fox Chase Cancer Center | 2010-10-01 |
| Safety and Pharmacokinetic Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein in Subjects With Hemophilia B (NCT01233440) | CSL Behring | 2010-10-01 |
| A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors (NCT00634231) | Candel Therapeutics, Inc. | 2010-10-01 |
| A Study of the Tolerability, Safety, and Pharmacokinetics of ISU302 in Healthy Volunteers (NCT01881633) | ISU Abxis Co., Ltd. | 2010-10-01 |
| Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies (NCT01243359) | National Cancer Institute (NCI) | 2010-10-01 |
| Pharmacokinetics in Adolescents (NCT01196689) | AstraZeneca | 2010-10-01 |
| RV568 - Viral Challenge With RSV (NCT01230645) | Respivert Ltd | 2010-10-01 |
| To Compare the Safety, Tolerability, and Pharmacokinetics of QBX258 in Patients With Asthma (NCT01568762) | Novartis Pharmaceuticals | 2010-10-01 |
| Ecopipam Treatment of Tourette Syndrome (NCT01244633) | Psyadon Pharma | 2010-10-01 |
| Intramuscular Injection of Mesenchymal Stem Cell for Treatment of Children With Idiopathic Dilated Cardiomyopathy (NCT01219452) | Qingdao University | 2010-10-01 |
| A Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma (NCT01219010) | Janssen Research & Development, LLC | 2010-10-01 |
| Obatoclax Mesylate, Rituximab, and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NCT01238146) | National Cancer Institute (NCI) | 2010-10-01 |
| Safety and Efficacy of INCB007839 With Trastuzumab and Vinorelbine in Patients With Metastatic HER2+ Breast Cancer (NCT01254136) | Incyte Corporation | 2010-10-01 |
| A Phase 1, Open Label, Placebo-Controlled Study to Evaluate the Effect of GSK1349572 on Iohexol and Para-Aminohippurate Clearance in Healthy Subjects (NCT01214993) | ViiV Healthcare | 2010-10-01 |
| A Bioequivalence Study of 2 Formulations of Rabeprazole Sodium and Evaluation of the Effect of Food on Rabeprazole Sodium in Healthy Adult Volunteers (NCT01241409) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2010-10-01 |
| A Phase I Study of SB939 in Pediatric Patients With Refractory Solid Tumours and Leukemia (NCT01184274) | NCIC Clinical Trials Group | 2010-10-01 |
| Drug Interaction and Safety Between Pitavastatin and Valsartan (CWP-PTV-101) (NCT01232049) | Asan Medical Center | 2010-10-01 |
| Human Umbilical Cord Mesenchymal Stem Cells Transplantation for Patients With Decompensated Liver Cirrhosis (NCT01342250) | Shenzhen Beike Bio-Technology Co., Ltd. | 2010-10-01 |
| Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2) (NCT01225146) | David M. Brown, M.D. | 2010-10-01 |
| A Single Dose Study Of The Safety And Investigational Product Level Measurement In Healthy Subjects (NCT01284036) | Ablynx, a Sanofi company | 2010-10-01 |
| CP-690,550 Pharmacokinetics In Healthy Chinese Subjects (NCT01101919) | Pfizer | 2010-10-01 |
| Safety and Efficacy Study of Ursodeoxycholic Acid Therapy in Pediatric Primary Sclerosing Cholangitis (NCT01088607) | University of Tennessee | 2010-10-01 |
| TMS Measures of Plasticity and Excitatory/Inhibitory Ratio as Biomarkers: R-baclofen Effects in Normal Volunteers (NCT01172509) | Gonzalez-Heydrich, Joseph, M.D. | 2010-10-01 |
| Pilot Study to Evaluate the Safety and Efficacy of Ariva® Silver Wintergreen in Reducing Cigarette Craving in Smokers (NCT01337830) | Star Scientific, Inc | 2010-10-01 |
| Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination (NCT01119521) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-10-01 |
| Extension Study for the Evaluation of Finasteride in the Treatment of Chronic Central Serous Chorioretinopathy (NCT01227993) | National Eye Institute (NEI) | 2010-10-01 |
| Study to Evaluate the Use of Palifermin to Treat Toxic Epidermal Necrolysis (NCT02037347) | Brett King | 2010-10-01 |
| Pneumatic Medicine: A Transformative Treatment for Diabetic Peripheral Neuropathy (NCT01175928) | NormaTec Industries LP | 2010-10-01 |
| Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on Bioavailability (NCT01211197) | Boehringer Ingelheim | 2010-10-01 |
| A Dose Finding and Safety Study of Oral LEQ506 in Patients With Advanced Solid Tumors (NCT01106508) | Novartis Pharmaceuticals | 2010-10-01 |
| Standard Versus High-Dose Trivalent Inactivated Flu Vaccine in Pediatric Acute Lymphoblastic Leukemia Patients (NCT01216332) | Vanderbilt University | 2010-10-01 |
| ESBA1008 Safety, Tolerability and Effects in Wet Age-Related Macular Degeneration (AMD) Patients (NCT01304693) | Alcon Research | 2010-10-01 |
| Safety & Efficacy Study of Oral Panobinostat (LBH589) With Chemotherapy in Patients < 65 Years Old With Acute Myeloid Leukemia (AML) (NCT01242774) | Novartis Pharmaceuticals | 2010-10-01 |
| Spinal Analgesia for Colonic Resection Using an Enhanced Recovery After Surgery (ERAS) Program (NCT01477190) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2010-10-01 |
| An East Asian Study of LDE225 (NCT01208831) | Novartis Pharmaceuticals | 2010-10-01 |
| Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia (NCT01111292) | National Cancer Institute (NCI) | 2010-10-01 |
| Safety And Tolerability Of Multiple Dose Lersivirine For 21 Days In Healthy Subjects (NCT01230385) | Pfizer | 2010-10-01 |
| A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors (NCT01248949) | MedImmune LLC | 2010-10-01 |
| Randomized, Placebo-controlled Study to Evaluate Effects of E5555 on Renal Function Parameters and OCT2 Activity (NCT01241669) | Eisai Inc. | 2010-10-01 |
| RO4929097 and Whole-Brain Radiation Therapy or Stereotactic Radiosurgery in Treating Patients With Brain Metastases From Breast Cancer (NCT01217411) | National Cancer Institute (NCI) | 2010-10-01 |
| Rumination-focused CBT Training for the Prevention of Depression and Anxiety (NCT01223677) | VU University of Amsterdam | 2010-10-01 |
| Development of a New Non-radioactive Test for Measuring Glomerular Filtration Rate Using the Tetrapeptide N-acetyl-Ser-Asp-Lys-Pro-amide (AcSDKP-NH2) (NCT01588756) | Assistance Publique - Hôpitaux de Paris | 2010-10-01 |
| Pharmacokinetics, Safety and Tolerability of BI 671800 HEA Given Over 7 Days. A Randomised, Double Blind, Placebo Controlled Within Dose Groups Phase I Study in Healthy Male and Female Volunteers. (NCT01215773) | Boehringer Ingelheim | 2010-10-01 |
| A Bioequivalence Study of Two Azithromycin Tablet Formulations in Indonesian Healthy Subjects (NCT01602055) | PT Novell Pharmaceutical Laboratories | 2010-10-01 |
| Multiple Oral Doses Of PH-797804 In Healthy Japanese Adult Subjects (NCT01217918) | Pfizer | 2010-10-01 |
| Pazopanib in Combination With Capecitabine in Patients With Metastatic Breast Cancer (NCT01498458) | GBG Forschungs GmbH | 2010-10-01 |
| Safety and Efficacy Study of Nilotinib Combined With Mitoxantrone, Etoposide, and High-dose Cytarabine Induction Chemotherapy Followed by Consolidation for Patients With C-kit Positive Acute Myeloid Leukemia (NCT01222143) | University Health Network, Toronto | 2010-10-01 |
| Bi-trimalleolar Fracture and APOS System Treatment (NCT01127776) | Meir Medical Center | 2010-10-01 |
| Cell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating Lymphocytes (NCT01236573) | National Institutes of Health Clinical Center (CC) | 2010-10-01 |
| A Safety and Effectiveness Pilot Study of PRF-108 and PRF-110 in Healthy Volunteers (NCT00883194) | PainReform LTD | 2010-10-01 |